Cambridge Investment Research Advisors
EHC icon

Cambridge Investment Research Advisors’s Encompass Health EHC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$763K Sell
7,546
-29
-0.4% -$3K ﹤0.01% 2557
2026
Q1 		$733K Sell
7,575
-16
-0.2% -$1.64K ﹤0.01% 2452
2025
Q4 		$806K Sell
7,591
-156
-2% -$18.1K ﹤0.01% 2284
2025
Q3 		$984K Sell
7,747
-1,628
-17% -$194K ﹤0.01% 2066
2025
Q2 		$1.15M Sell
9,375
-222
-2% -$25.4K ﹤0.01% 1844
2025
Q1 		$972K Buy
9,597
+2,218
+30% +$217K ﹤0.01% 1888
2024
Q4 		$681K Sell
7,379
-556
-7% -$54.6K ﹤0.01% 2178
2024
Q3 		$767K Buy
7,935
+1,464
+23% +$132K ﹤0.01% 2061
2024
Q2 		$555K Sell
6,471
-24
-0.4% -$2.01K ﹤0.01% 2213
2024
Q1 		$536K Buy
6,495
+20
+0.3% +$1.47K ﹤0.01% 2218
2023
Q4 		$432K Buy
6,475
+119
+2% +$7.71K ﹤0.01% 2307
2023
Q3 		$427K Sell
6,356
-148
-2% -$10.2K ﹤0.01% 2221
2023
Q2 		$440K Buy
6,504
+31
+0.5% +$1.94K ﹤0.01% 2231
2023
Q1 		$350K Sell
6,473
-1,806
-22% -$105K ﹤0.01% 2350
2022
Q4 		$495K Buy
8,279
+3,319
+67% +$180K ﹤0.01% 2020
2022
Q3 		$224K Sell
4,960
-743
-13% -$37.2K ﹤0.01% 2604
2022
Q2 		$254K Buy
5,703
+75
+1% +$3.85K ﹤0.01% 2531
2022
Q1 		$318K Buy
+5,628
New +$294K ﹤0.01% 2499
2020
Q2 		– Sell
-4,027
Closed -$205K – 2470
2020
Q1 		$205K Sell
4,027
-525
-12% -$30.3K ﹤0.01% 1914
2019
Q4 		$251K Buy
+4,552
New +$247K ﹤0.01% 2031
2019
Q1 		– Sell
-10,849
Closed -$533K – 2301
2018
Q4 		$533K Buy
10,849
+5,166
+91% +$294K 0.01% 1278
2018
Q3 		$352K Buy
5,683
+96
+2% +$5.84K ﹤0.01% 1683
2018
Q2 		$301K Buy
5,587
+193
+4% +$9.64K ﹤0.01% 1724
2018
Q1 		$245K Sell
5,394
-6,026
-53% -$258K ﹤0.01% 1822
2017
Q4 		$449K Sell
11,420
-601
-5% -$22.9K 0.01% 1374
2017
Q3 		$443K Sell
12,021
-1,551
-11% -$55.3K 0.01% 1310
2017
Q2 		$523K Sell
13,572
-630
-4% -$23.1K 0.01% 1177
2017
Q1 		$484K Buy
+14,202
New +$466K 0.01% 1098

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cambridge Investment Research Advisors's EHC Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Encompass Health (EHC) stake by 0.38% in Q2 2026, selling an estimated $3K and leaving 7,546 shares worth $763K. The position accounts for ﹤0.01% of the portfolio, ranked #2557.

Cambridge Investment Research Advisors first reported a position in EHC in Q1 2017 and has held it in 28 quarters since. The position peaked at $1.15M in Q2 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Cambridge Investment Research Advisors held 7,546 shares of Encompass Health worth $763K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 29 Encompass Health shares in Q2 2026, an estimated $3K.
  • Encompass Health made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2557 holding.
  • Cambridge Investment Research Advisors first reported a position in Encompass Health in Q1 2017 and has held it in 28 quarters since.
  • Cambridge Investment Research Advisors's Encompass Health position peaked at $1.15M in Q2 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.